PGNY analyst estimates

Progyny (PGNY) analyst ratings, the average price target and its range, and every firm's latest call.

PGNY analyst ratings and price targets

DateFirmCallTarget
Sep 8, 2026JefferiesProgyny (PGNY) PT Raised to $33 at Citizens on CalPERS Selection as Fertility Benefits Partner$33.00
Aug 20, 2026Wells FargoProgyny initiated with an Overweight at Wells Fargo$37.00
Aug 13, 2026Truist FinancialProgyny price target raised to $36 from $33 at Truist$36.00
Aug 12, 2026BarclaysProgyny price target lowered to $30 from $34 at Barclays$30.00
Aug 7, 2026Canaccord GenuityProgyny price target lowered to $35 from $36 at Canaccord$35.00
Jul 28, 2026BarclaysBarclays Downgrades Progyny (PGNY) to Equalweight$34.00
Jul 24, 2026BTIGProgyny price target raised to $40 from $30 at BTIG$40.00
Jul 22, 2026Leerink PartnersProgyny price target raised to $38 from $30 at Leerink$38.00
Jul 21, 2026Canaccord GenuityProgyny price target raised to $36 from $30 at Canaccord$36.00
Jul 13, 2026KeyBancProgyny price target raised to $35 from $30 at KeyBanc$35.00
May 19, 2026Canaccord GenuityProgyny upgraded to Buy from Hold at Canaccord$30.00
May 15, 2026BarclaysProgyny price target raised to $27 from $23 at Barclays$27.00
Mar 6, 2026JefferiesProgyny (PGNY) PT Lowered to $30 at Jefferies$30.00
Mar 2, 2026Truist FinancialProgyny (PGNY) PT Lowered to $28 at Truist Securities$28.00
Jan 21, 2026J.P. MorganProgyny price target raised to $35 from $30 at BTIG$35.00

Updated 2026-11-02 23:14 UTC